Bicycle Health

Bicycle Health is a virtual healthcare provider specializing in opioid use disorder (OUD) treatment. The company offers medication-assisted treatment (MAT) through telemedicine, primarily prescribing Suboxone (buprenorphine) to patients across multiple states. Bicycle Health's treatment model combines FDA-approved medications with behavioral health support, including access to medical experts, recovery coaching, customized treatment plans, and peer support groups. The company utilizes a comprehensive approach to virtual MAT, delivering care through full-time clinical staff and wraparound support services. Bicycle Health claims its patients stay in treatment past 90 days at a rate nearly double the industry average.

Bicycle Health's services include virtual video visits, medication management, support groups, and at-home drug testing. The company has expanded its offerings to include both oral and extended-release injectable formulations of buprenorphine. 

As of February 2024, Bicycle Health reported operating in 32 states and having served more than 33,000 patients since its inception.

Key customers and partnerships

Bicycle Health has established partnerships with several major health insurance providers and healthcare organizations, accepting coverage from insurers such as Cigna, Blue Cross Blue Shield, Aetna, and Humana across various states. 

In April 2022, the company entered an agreement with Marvin to provide OUD treatment to healthcare professionals. By August 2022, Bicycle Health partnered with Tele911, allowing licensed social workers responding to 911 calls related to opioid overdoses or symptoms to refer patients to the company for long-term care. That same month, Bicycle Health also collaborated with Evernorth, expanding access to virtual OUD treatment through Evernorth’s behavioral health network. In March 2023, the company teamed up with Wellpath and the Federal Bureau of Prisons to offer virtual OUD treatment to incarcerated individuals. 

In September 2023, Bicycle Health partnered with Albertsons Companies to make buprenorphine extended-release injections (Sublocade) available across 17 states, with plans for further expansion. Furthermore, in February 2024, the company partnered with Talkspace, enabling cross-referrals between their services to broaden access to OUD treatment and mental health support for patients.